Should You Buy Puma Biotechnology Inc (PBYI) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
Puma Biotechnology Inc (PBYI) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak financial performance, negative trading trends, and lacks positive catalysts or strong technical signals to support a buy decision.
Technical Analysis
The stock's MACD is positive but contracting, RSI is neutral at 48.462, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock closed below its pivot level (6.572), and regular market change was -6.41%, indicating bearish sentiment. Support levels are at 6.129 and 5.855, suggesting further downside risk.
